AXA Sel Carmignac Convictions Rtl R EUR

Performance History31/03/2024
Growth of 1,000 (EUR)
AXA Sel Carmignac Convictions Rtl R EUR
Fund15.00.1-11.65.26.0
+/-Cat12.8-9.60.6-3.01.6
+/-Idx10.8-11.40.7-5.81.3
 
Key Stats
NAV
29/04/2024
 EUR 122.68
Day Change -0.21%
Morningstar Category™ EUR Flexible Allocation - Global
ISIN IE00B8QW1J18
Fund Size (Mil)
29/04/2024
 EUR 44.87
Share Class Size (Mil)
29/04/2024
 EUR 34.09
Max Initial Charge 5.00%
Ongoing Charge
09/02/2024
  2.55%
Investment Objective: AXA Sel Carmignac Convictions Rtl R EUR
The investment objective of the AXA Selection Carmignac Convictions is to seek medium-term capital growth. Carmignac Gestion will select Investments opportunistically (following an assessment of their value and/or potential for value) by seeking to take advantage of market conditions at any particular point in time.
Returns
Trailing Returns (EUR)29/04/2024
YTD5.06
3 Years Annualised-1.76
5 Years Annualised3.07
10 Years Annualised2.24
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
14/12/2012
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
Not BenchmarkedMorningstar EU Mod Gbl Tgt Alloc NR EUR
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthNot Specific
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA Sel Carmignac Convictions Rtl R EUR-
Morningstar Style Box®
Equity Style
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Fixed Income
Effective Maturity-
Effective Duration-
Top 5 Regions%
No Data Available
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
No Data Available
AXA Sel Carmignac Convictions Rtl R EUR
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures